CAP in Cell Experiments: A Key Reference for Biomedical Research
1. Research Background and Objectives
Background
Objectives
2. Experimental Methods
(1)Cell Culture: Human skin-derived target cells (e.g., keratinocytes) were cultured in DMEM medium supplemented with fetal bovine serum and antibiotics, maintained in a 5% CO₂ incubator at 37°C.- Molecular expression: qPCR (to measure mRNA levels of IL-8, TGF-β1, TGF-β2, HBD-2, MBD-2/3) and Western blot (to quantify corresponding protein levels).
- Cell proliferation: XTT assay (assessed at 24/48/72 h).
- Cell migration: Scratch wound assay (migration rate evaluated at 7 h, 12 h).
- In vivo validation: Mouse models were established, followed by qPCR detection of target factor mRNA levels.
3. Primary Results

4. Key Conclusions
(1)CAP can significantly upregulate the expression of regulatory factors (IL-8, TGF-β1/β2, HBD-2, MBD-2/3) in skin-related cells (at the mRNA or protein level), which may underpin CAP’s regulatory effects on cell function.
(2)Within the experimental treatment parameters, CAP does not alter the proliferation or migration of target cells—indicating it modulates factor expression without compromising basic cell viability (within a safe dose range).
(3)CAP’s regulatory effects on factor expression are consistent in both in vitro cell experiments and in vivo mouse models, confirming the reliability of the findings.
5. Research Significance
(1)Theoretical Significance: This study clarifies CAP’s regulatory effects on key factor expression in skin-related cells, expanding the theoretical framework of CAP-cell interactions.
(2)Experimental Basis: It provides specific experimental data (factor expression changes, cell function metrics) for CAP’s use in skin-related research, serving as a reference for future experimental design.
(3)Clinical Translation Value: By demonstrating that CAP modulates skin-related regulatory factor expression (without impairing basic cell viability), it lays groundwork for CAP’s clinical application in skin disease treatment (e.g., wound healing, inflammatory skin conditions).
References
[1] Gan L, Jiang J, Duan JW, Wu XJZ, Zhang S, Duan XR, Song JQ, Chen HX. Cold atmospheric plasma applications in dermatology: a systematic review. J Biophotonics. 2021;14:e202000415.
[2] Bekeschus S, von Woedtke T, Emmert S, Schmidt A. Medical gas plasma-stimulated wound healing: evidence and mechanisms. Redox Biol. 2021;46: 102116.
[3] Arndt S, Unger P, Berneburg M, Bosserhoff AK, Karrer S. Cold atmospheric plasma (CAP) activates angiogenesis-related molecules in skin keratinocytes, fibroblasts and endothelial cells and improves wound angiogenesis in an autocrine and paracrine mode. J Dermatol Sci. 2018;89:181–90.
[4] Hasse S, Duong Tran T, Hahn O, Kindler S, Metelmann HR, von Woedtke T, Masur K. Induction of proliferation of basal epidermal keratinocytes by cold atmospheric-pressure plasma. Clin Exp Dermatol. 2016;41:202–9.
[5] Arndt S, Landthaler M, Zimmermann JL, Unger P, Wacker E, Shimizu T, Karrer S. Effects of cold atmospheric plasma (CAP) on ß-defensins, inflammatory cytokines, and apoptosis-related molecules in keratinocytes in vitro and in vivo. PLoS ONE. 2015;10(8): e0120041.
[6] Lou BS, Hsieh JH, Chen CM, Hou CW, Wu HY, Chou PY, Lai CH, Lee JW. Helium/argon-generated cold atmospheric plasma facilitates cutaneous wound healing. Front Bioeng Biotechnol. 2020;8:683
[7] Barton A, Wende K, Bundscherer L, Hasse S, Schmidt A, Bekeschus S, Masur K. Nonthermal plasma increases expression of wound healing related genes in a keratinocyte cell line. Plasma Med. 2013;3(3):287–98.


